Johnson & Johnson Tries to Buy Surgical Robotics Firm, Sources Say 

  • Deal may value Auris at premium to latest $2 billion valuation
  • J&J seeking to boost cutting-edge surgical robotics technology

Photographer: Scott Eells/Bloomberg

Lock
This article is for subscribers only.

Johnson & Johnson, the world’s largest maker of health-care products, is pursuing an acquisition of Auris Health Inc. in a deal that would bring it cutting-edge surgical robotics technology, people with knowledge of the matter said.

J&J is seeking to purchase Auris at a premium to the valuation from its latest funding round, according to the people, who asked not to be identified because the information is private. That financing valued the Redwood City, California-based company at about $2 billion, one person said.